Venous thromboembolism - dabigatran
Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults
| Guidance type: Technology appraisal |
| Date issued: September 2008 |
We will consult on our review plans for this guidance in June 2011. |
| Reference: TA157 |
SummaryDabigatran etexilate is recommended as a possible treatment to reduce the risk of venous thromboembolism in adults who have surgery to replace their hip or knee joint. |
| Top |
DocumentsFor healthcare professionals
For patients, carers and the public
Background information |
Implementing this guidanceAny further information NICE has produced to help the NHS implement this guideline locally is linked to below: |
| Top |
